Bevacizumab exerts its anti-tumor effect by inhibiting which process?
Show answer and explanation
Correct answer: Angiogenesis
Bevacizumab is an anti-angiogenic agent that binds to Vascular Endothelial Growth Factor (VEGF). By neutralizing VEGF, it prevents the formation of new blood vessels that tumors need to grow and metastasize.
Keep practicing
More Monoclonal Antibodies questions
- Which of the following is a potential serious side effect of Natalizumab, used in the treatment of Multiple Sclerosis?
- Denosumab mimics the action of osteoprotegerin (OPG) by binding to which target?
- Which agent is used as an 'antidote' to reverse the effects of the anticoagulant Dabigatran?
- Adalimumab is distinguished from Infliximab primarily because Adalimumab is:
- What is the specific target of Cetuximab in the treatment of colorectal and head and neck cancers?
- Eculizumab is used in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) by targeting which component?